Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-03-08 @ 11:01 PM
Study NCT ID:
NCT02809833
Status:
COMPLETED
Last Update Posted:
2016-10-24
First Post:
2016-06-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Use of Tocilizumab for Rheumatoid Arthritis (RA) in Daily Routine
Sponsor:
Hoffmann-La Roche
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ML22734
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None